Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions (Q48777649)

15 February 2018

title

Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions (English)

1 reference

15 February 2018

0 references

Gobin SJ

1

1 reference

15 February 2018

Montagne L

2

1 reference

15 February 2018

Van Zutphen M

3

1 reference

15 February 2018

Van Der Valk P

4

1 reference

15 February 2018

Van Den Elsen PJ

5

1 reference

15 February 2018

De Groot CJ

6

1 reference

15 February 2018

publication date

1 October 2001

1 reference

15 February 2018

published in

Glia

1 reference

15 February 2018

volume

36

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

68-77

1 reference

15 February 2018

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

cites work

1 reference

Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions

21 January 2018

1 reference

Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology.

21 January 2018

1 reference

Regulation of MHC class II expression in the central nervous system

21 January 2018

1 reference

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures

21 January 2018

1 reference

The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes

21 January 2018

1 reference

Microglia: Intrinsic immuneffector cell of the brain

21 January 2018

1 reference

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes

21 January 2018

1 reference

Microglia as mediators of inflammatory and degenerative diseases

21 January 2018

1 reference

Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions

21 January 2018

1 reference

The pathology of multiple sclerosis: a historical perspective

21 January 2018

1 reference

Tumor necrosis factor identified in multiple sclerosis brain

21 January 2018

1 reference

Interpreting MHC class I expression and class I/class II reciprocity in the CNS: reconciling divergent findings

21 January 2018

1 reference

Induction of MHC class I expression by the MHC class II transactivator CIITA.

21 January 2018

1 reference

Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha

21 January 2018

1 reference

Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines

21 January 2018

1 reference

The bare lymphocyte syndrome and the regulation of MHC expression

21 January 2018

1 reference

Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis

21 January 2018

1 reference

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

21 January 2018

1 reference

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

Indictment of the microglia as the villain in multiple sclerosis

21 January 2018

1 reference

Regulation of MHC gene expression

21 January 2018

1 reference

Pathogenesis of tissue injury in MS lesions

21 January 2018

1 reference

Shared regulatory elements in the promoters of MHC class I and class II genes

21 January 2018

1 reference

Regulation of MHC class I and II gene transcription: differences and similarities

21 January 2018

1 reference

The common regulatory pathway of MHC class I and class II transactivation

21 January 2018

1 reference

Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS.

21 January 2018

1 reference

Molecular mechanisms of microglial activation

21 January 2018

1 reference

Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions

21 January 2018

1 reference

Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules

21 January 2018

1 reference

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

21 January 2018

1 reference

Astrocytic factors deactivate antigen presenting cells that invade the central nervous system.

21 January 2018

1 reference

Microglia-derived macrophages in early multiple sclerosis plaques

21 January 2018

1 reference

Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1

21 January 2018

1 reference

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro

21 January 2018

1 reference

Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/GLIA.1096

1 reference

15 February 2018

1 reference

15 February 2018